Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 4, 2017, Pages 1383-1386.e6

  Hasegawa, Kohei ^a   Mansbach, Jonathan M ^b   Ajami, Nadim J ^c   Petrosino, Joseph F ^c   Freishtat, Robert J ^d   Teach, Stephen J ^d   Piedra, Pedro A ^c   Camargo, Carlos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; RNA 16S; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ARTICLE; BRONCHIOLITIS; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; HAEMOPHILUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MICROFLORA; MORAXELLA; NASOPHARYNGEAL ASPIRATION; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOCOCCUS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; IMMUNOLOGY; MICROBIOLOGY; MULTICENTER STUDY; NOSE MUCOSA; PHARYNX; PROSPECTIVE STUDY;

ANTIMICROBIAL CATIONIC PEPTIDES; BRONCHIOLITIS; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; NASAL MUCOSA; PHARYNX; PROSPECTIVE STUDIES;

EID: 85008225342     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.09.037     Document Type: Article

References (35)

1. 1 Ralston, S.L., Lieberthal, A.S., Meissner, H.C., Alverson, B.K., Baley, J.E., Gadomski, A.M., et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134 (2014), e1474–e1502.
2. 2 de Steenhuijsen Piters, W.A., Heinonen, S., Hasrat, R., Bunsow, E., Smith, B., Suarez-Arrabal, M.C., et al. Nasopharyngeal microbiota, host transcriptome and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med 194 (2016), 1104–1115.
3. 3 Mansbach, J.M., Hasegawa, K., Henke, D.M., Ajami, N.J., Petrosino, J.F., Shaw, C.A., et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol 137 (2016), 1909–1913.
4. 4 Hasegawa, K., Mansbach, J.M., Ajami, N.J., Espinola, J.A., Henke, D.M., Petrosino, J.F., et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalized for bronchiolitis. Eur Respir J 48 (2016), 1329–1339.
5. 5 Hilchie, A.L., Wuerth, K., Hancock, R.E., Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 9 (2013), 761–768.
6. 6 Mansbach, J.M., Piedra, P.A., Borregaard, N., Martineau, A.R., Neuman, M.I., Espinola, J.A., et al. Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. J Allergy Clin Immunol 130 (2012), 1007–1008.e1.
7. 7 Pound, L.D., Patrick, C., Eberhard, C.E., Mottawea, W., Wang, G.S., Abujamel, T., et al. Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration, and selected gut bacteria. Diabetes 64 (2015), 4135–4147.
8. 8 Neumann, A., Berends, E.T., Nerlich, A., Molhoek, E.M., Gallo, R.L., Meerloo, T., et al. The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps. Biochem J 464 (2014), 3–11.
9. 9 Kovach, M.A., Ballinger, M.N., Newstead, M.W., Zeng, X., Bhan, U., Yu, F.S., et al. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J Immunol 189 (2012), 304–311.
10. 10 Marsh, R.L., Kaestli, M., Chang, A.B., Binks, M.J., Pope, C.E., Hoffman, L.R., et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome, 4, 2016, 37.
11. Mansbach, J.M., Hasegawa, K., Henke, D.M., Ajami, N.J., Petrosino, J.F., Shaw, C.A., et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol 137 (2016), 1909–1913.
12. Hasegawa, K., Mansbach, J.M., Ajami, N.J., Espinola, J.A., Henke, D.M., Petrosino, J.F., et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalized for bronchiolitis. Eur Respir J 48 (2016), 1329–1339.
13. Ralston, S.L., Lieberthal, A.S., Meissner, H.C., Alverson, B.K., Baley, J.E., Gadomski, A.M., et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134 (2014), e1474–e1502.
14. Hasegawa, K., Jartti, T., Mansbach, J.M., Laham, F.R., Jewell, A.M., Espinola, J.A., et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the US and Finland. J Infect Dis 211 (2015), 1550–1559.
15. Mansbach, J.M., Piedra, P.A., Teach, S.J., Sullivan, A.F., Forgey, T., Clark, S., et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 166 (2012), 700–706.
16. Beckham, J.D., Cadena, A., Lin, J., Piedra, P.A., Glezen, W.P., Greenberg, S.B., et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50 (2005), 322–330.
17. Human Microbiome Project Consortium. A framework for human microbiome research. Nature 486 (2012), 215–221.
18. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
19. PowerSoil® DNA. Isolation Kit. Available at: https://mobio.com/media/wysiwyg/pdfs/protocols/12888.pdf Accessed May 23, 2016.
20. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7 (2010), 335–336.
21. Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Huntley, J., Fierer, N., et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6 (2012), 1621–1624.
22. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
23. Edgar, R.C., Flyvbjerg, H., Error filtering, pair assembly and error correction for next-generation sequencing reads. Bioinformatics 31 (2015), 3476–3482.
24. Edgar, R.C., UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10 (2013), 996–998.
25. Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41 (2013), D590–D596.
26. Lozupone, C., Lladser, M.E., Knights, D., Stombaugh, J., Knight, R., UniFrac: an effective distance metric for microbial community comparison. ISME J 5 (2011), 169–172.
27. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 71 (2005), 8228–8235.
28. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
29. Rousseeuw, P.J., Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 20 (1987), 53–65.
30. Vandamme, D., Landuyt, B., Luyten, W., Schoofs, L., A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 280 (2012), 22–35.
31. Hilchie, A.L., Wuerth, K., Hancock, R.E., Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 9 (2013), 761–768.
32. Jartti, T., Hasegawa, K., Mansbach, J.M., Piedra, P.A., Camargo, C.A. Jr., Rhinovirus-induced bronchiolitis: lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol 136 (2015), 509–512.e11.
33. Mansbach, J.M., Piedra, P.A., Stevenson, M.D., Sullivan, A.F., Forgey, T.F., Clark, S., et al. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics 130 (2012), e492–e500.
34. Hasegawa, K., Mansbach, J.M., Camargo, C.A. Jr., Infectious pathogens and bronchiolitis outcomes. Expert Rev Anti Infect Ther 12 (2014), 817–828.
35. Hasegawa, K., Linnemann, R.W., Mansbach, J.M., Ajami, N.J., Espinola, J.A., Petrosino, J.F., et al. The fecal microbiota profile and bronchiolitis in infants. Pediatrics, 138(1), 2016 Jul.